|
1
|
Multiparametric magnetic resonance imaging of prostate
|
|
TID 4300
|
|
1.1
|
Language of Content Item and Descendants
|
English
|
TID 1204
|
|
1.2
|
Observer Type
|
Person
|
TID 1001
|
|
1.3
|
Person Observer Name
|
Smith^John
|
TID 1003
|
|
1.4
|
Subject name
|
Jackson^Paul
|
TID 1007
|
|
1.5
|
Subject ID
|
S98765432
|
TID 1007
|
|
1.6
|
Reporting System
|
PI-RADS v2.0
|
TID 4300
|
|
1.7
|
Image Library
|
|
TID 1600
|
|
1.7.1
|
Image Library Group
|
|
TID 1600
|
|
1.7.1.1
|
Modality
|
MR
|
TID 1602
|
|
1.7.1.2
|
Magnetic field strength
|
3 T
|
TID 1606
|
|
1.4.1.3
|
MR coil
|
Endorectal
|
TID 1606
CID 6349
|
|
1.7.1.4
|
MR signal intensity
|
T2 Weighted MR Signal Intensity
|
TID 1606
CID 6311
|
|
1.7.1.5
|
Cross-sectional scan plane orientation
|
Axial
|
TID 1606
CID 6312
|
|
1.7.1.6
|
IMAGE
|
|
TID 1601
|
|
1.7.1.n
|
IMAGE
|
|
TID 1601
|
|
1.7.2
|
Image Library Group
|
|
TID 1600
|
|
1.7.2.1
|
Modality
|
MR
|
TID 1602
|
|
1.7.2.2
|
Magnetic field strength
|
3 T
|
TID 1606
|
|
1.7.2.3
|
MR coil
|
Endorectal
|
TID 1606
CID 6349
|
|
1.7.2.4
|
MR signal intensity
|
Diffusion weighted
|
TID 1606
CID 6311
|
|
1.7.2.5
|
Cross-sectional scan plane orientation
|
Axial
|
TID 1606
CID 6312
|
|
1.7.2.6
|
Source image diffusion b-value
|
50 s/mm2
|
TID 1606
|
|
1.7.2.7
|
Source image diffusion b-value
|
400 s/mm2
|
TID 1606
|
|
1.7.2.8
|
Source image diffusion b-value
|
800 s/mm2
|
TID 1606
|
|
1.7.2.9
|
Source image diffusion b-value
|
1400 s/mm2
|
TID 1606
|
|
1.7.2.7
|
IMAGE
|
|
TID 1601
|
|
1.7.2.n
|
IMAGE
|
|
TID 1601
|
|
1.7.3
|
Image Library Group
|
|
TID 1600
|
|
1.7.3.1
|
Modality
|
MR
|
TID 1602
|
|
1.7.3.2
|
Magnetic field strength
|
3 T
|
TID 1606
|
|
1.7.3.3
|
MR coil
|
Endorectal
|
TID 1606
CID 6349
|
|
1.7.3.4
|
MR signal intensity
|
Dynamic Contrast-Enhanced Acquisition
|
TID 1606
CID 6311
|
|
1.7.3.5
|
Cross-sectional scan plane orientation
|
Axial
|
TID 1606
CID 6312
|
|
1.7.3.6
|
Prostate DCE temporal resolution
|
10 s
|
TID 1608
|
|
1.7.3.7
|
IMAGE
|
|
TID 1601
|
|
1.7.3.n
|
IMAGE
|
|
TID 1601
|
|
1.8
|
General Relevant Patient Information
|
|
TID 9007
CID 6327
|
|
1.8.1.1
|
Indicated Problem
|
Elevated Prostate Specific Antigen
|
TID 9007
CID 6327
|
|
1.8.2
|
Genitourinary History
|
|
TID 4301
|
|
1.8.2.1
|
Diagnostic procedure
|
|
TID 4301
|
|
1.8.2.1.1
|
Blood lab measurements
|
|
TID 1700
CID 6352
|
|
1.8.2.1.1.1
|
Sampling DateTime
|
19860101120101-0400
|
TID 1700
|
|
1.8.2.1.1.2
|
Prostate Cancer Antigen Measurement
|
12.1 ng/mL
|
TID 1700
TID 300
|
|
1.9
|
Prostate MRI relevant procedure information
|
|
TID 4300
|
|
1.9.1
|
Contrast administered
|
Gadobutrol
|
TID 3106
CID 3409
CID 12
|
|
1.9.1.1
|
Route of administration
|
Intra-arterial route
|
TID 3106
CID 11
|
|
1.9.1.2
|
Volume administered
|
10 mL
|
TID 3106
CID 3410
|
|
1.9.1.3
|
Rate of administration
|
2 ml/s
|
TID 3106
CID 3410
|
|
1.9.2
|
Endorectal coil used
|
No
|
TID 4300
CID 231
|
|
1.10
|
Imaging study quality
|
|
TID 1701
|
|
1.10.1
|
Quality Assessment
|
Usable - Meets the quality control standard
|
TID 1701
CID 6044
|
|
1.10.2
|
Quality Control Standard
|
PI-RADS 2.0 prostate MRI acquisition requirements
|
TID 1701
CID 6353
|
|
1.10.3
|
Imaging Series Quality
|
|
TID 1701
|
|
1.10.3.1
|
Series Instance UID
|
|
TID 1701
|
|
1.10.3.2
|
Quality Assessment
|
Usable - Meets the quality control standard
|
TID 1701
CID 6044
|
|
1.10.3.3
|
Quality Control Standard
|
Institutionally defined quality control standard
|
TID 1701
CID 6326
|
|
1.10.3.4
|
Quality Finding
|
Distortion artifact in the area of interest
|
TID 1701
CID 6318
|
|
1.11
|
Prostate Imaging Findings
|
|
TID 4302
|
|
1.11.1
|
Overall Prostate Finding
|
|
TID 4303
|
|
1.11.1.1
|
Tracking Identifier
|
"Prostate"
|
TID 4303
|
|
1.11.1.2
|
Tracking Unique Identifier
|
2.999.1
|
TID 4303
|
|
1.11.1.3
|
Finding
|
Entire
|
TID 4303
|
|
1.11.1.4
|
Finding site
|
Prostate
|
TID 4303
|
|
1.11.1.5
|
Measurement Group
|
|
TID 1501
|
|
1.11.1.5.1
|
Height
|
5 mm
|
TID 300
CID 7470
|
|
1.11.1.5.1.1
|
Source
|
SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment
|
TID 320
|
|
1.11.1.5.1.1.1
|
(none)
|
IMAGE - MR image #1
|
TID 320
|
|
1.11.1.5.2
|
Width
|
4 mm
|
TID 300
CID 7470
|
|
1.11.1.5.2.1
|
Source of Measurement
|
SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment
|
TID 320
|
|
1.11.1.5.2.1.1
|
(none)
|
IMAGE - MR image #2
|
TID 320
|
|
1.11.1.5.3
|
Length
|
4 mm
|
TID 300
CID 7470
|
|
1.11.1.5.3.1
|
Source
|
SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment
|
TID 320
|
|
1.11.1.5.3.1.1
|
(none)
|
IMAGE - MR image #3
|
TID 320
|
|
1.11.1.6
|
Peripheral zone
|
|
TID 4303
CID 6300
|
|
1.11.1.6.1
|
Signal characteristics
|
Heterogeneous
|
TID 4303
CID 6334
CID 6344
|
|
1.11.1.6.2
|
Signal characteristics
|
Slightly heterogeneous high signal
|
TID 4303
CID 6334
|
|
1.11.1.7
|
Transition zone
|
|
TID 4303
CID 6300
|
|
1.11.1.7.1
|
Signal characteristics
|
Heterogeneous
|
TID 4303
CID 6334
CID 6344
|
|
1.11.2
|
Localized Prostate Finding
|
|
TID 4304
|
|
1.11.2.1
|
Tracking Identifier
|
"Lesion 1"
|
TID 4304
|
|
1.11.2.2
|
Tracking Unique Identifier
|
2.999.2
|
TID 4304
|
|
1.11.2.3
|
Finding
|
Index lesion
|
TID 4304
CID 6337
|
|
1.11.2.4
|
Finding Site
|
Right anterior middle peripheral zone of prostate
|
TID 4304
CID 6300
|
|
1.11.2.5
|
Measurement Group
|
|
TID 1501
|
|
1.11.2.5.1.1
|
Length
|
1.1 cm
|
TID 300
CID 7470
|
|
1.11.2.5.1.1.1
|
Source
|
SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment
|
TID 300
|
|
1.11.2.5.1.1.1.1
|
(none)
|
IMAGE - MR image #4
|
TID 1410
|
|
1.11.2.6
|
PI-RADS Localized Abnormality Assessment
|
|
TID 4306
|
|
1.11.2.6.1
|
Index Lesion
|
Yes
|
TID 4306
CID 231
|
|
1.11.2.6.2
|
PI-RADS T2WI Lesion Assessment
|
|
TID 4306
|
|
1.11.2.6.2.1
|
PI-RADS T2WI Lesion Assessment Category
|
PI-RADS 5 - T2WI PZ Very high
|
TID 4306
CID 6329
|
|
1.11.2.6.2.2
|
Signal characteristics
|
Homogeneous
|
TID 4306
CID 6334
CID 6335
|
|
1.11.2.6.2.3
|
Signal characteristics
|
Hypointense
|
TID 4306
CID 6334
CID 6335
|
|
1.11.2.6.3
|
PI-RADS DWI Lesion Assessment
|
|
TID 4306
|
|
1.11.2.6.3.1
|
PI-RADS DWI Lesion Assessment Category
|
PI-RADS 5 - DWI Very high
|
TID 4306
CID 6331
|
|
1.11.2.6.3.2
|
Signal characteristics
|
Hyperintense
|
TID 4306
CID 6334
CID 6335
|
|
1.11.2.6.3.3
|
Status of extraprostatic extension of nodal tumor
|
Present
|
TID 4306
CID 6334
CID 6335
|
|
1.11.2.6.4
|
PI-RADS DCE Lesion Assessment
|
|
TID 4306
|
|
1.11.2.6.4.1
|
PI-RADS DCE Lesion Assessment Category
|
PI-RADS DCE +ve
|
TID 4306
CID 6332
|
|
1.11.2.6.5
|
PI-RADS Lesion Assessment Category
|
PI-RADS 5 - Very high (lesion)
|
TID 4306
CID 6328
|
|
1.11.3
|
PI-RADS Overall Assessment Category
|
PI-RADS 5 - Very high
|
TID 4302
CID 6325
|